-
Supernus Pharma Should Have More Strength After Epilepsy Drug Patent Decision, Northland's Buck Says
Thursday, March 10, 2016 - 12:23pm | 382Read More...Supernus Pharmaceuticals Inc (NASDAQ: SUPN) is up more than 3 percent Thursday and more than 17 percent year-to-date. According to a press release, Supernus' most recent earnings release earlier in March came in as records for both the fourth quarter and the full year 2015. "2015 was...
-
Supernus Up 3.7%, Federal Court Says Actavis Is Infringing On Patents
Monday, February 8, 2016 - 1:51pm | 233Read More...Supernus Pharmaceuticals Inc (NASDAQ: SUPN), a specialty pharmaceutical company that develops treatments for central nervous system diseases, were trading higher by more than 3 percent on Monday. Supernus Pharmaceuticals announced earlier in the morning that Judge Renee Marie Bumb of the United...
